Isotopic CO.sub.2 laser and method of use for medical treatment
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 5, 1991
Grant Date -
N/A
app pub date -
Dec 21, 1989
filing date -
Dec 21, 1989
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A medical treatment laser is disclosed that minimizes absorption of laser energy along the beam path by using a lasing medium having a principal emission at a wavelength shifted from the absorption wavelength. In the preferred embodiment, a CO.sub.2 laser filled with the .sup.13 C.sup.16 O.sub.2 isotope is used. The .sup.13 C.sup.16 O.sub.2 isotope generates a laser beam having a principal emission wavelength near 11.2 microns. The absorption of this wavelength in the conventional CO.sub.2 purge and insufflation gases is quite small compared to the absorption of the 10.59 micron wavelength emitted by the standard CO.sub.2 isotope. The difference in absorption allows the power generated by the laser to be maximally transmitted to the medical treatment site. In addition, the 11.2 micron line has a greater coefficient of absorption in human tissue, thereby enhancing surgery.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully